Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Long-Term Debt Repayments (2016 - 2024)

Prestige Consumer Healthcare has reported Long-Term Debt Repayments over the past 15 years, most recently at $60.0 million for Q4 2024.

  • Quarterly results put Long-Term Debt Repayments at $60.0 million for Q4 2024, down 7.69% from a year ago — trailing twelve months through Sep 2025 was $60.0 million (down 72.09% YoY), and the annual figure for FY2025 was $135.0 million, down 40.0%.
  • Long-Term Debt Repayments for Q4 2024 was $60.0 million at Prestige Consumer Healthcare, up from $40.0 million in the prior quarter.
  • Over the last five years, Long-Term Debt Repayments for PBH hit a ceiling of $475.0 million in Q3 2021 and a floor of -$352.0 million in Q1 2020.
  • Median Long-Term Debt Repayments over the past 5 years was $55.0 million (2022), compared with a mean of $49.4 million.
  • Biggest five-year swings in Long-Term Debt Repayments: plummeted 276.0% in 2020 and later surged 541.89% in 2021.
  • Prestige Consumer Healthcare's Long-Term Debt Repayments stood at $74.0 million in 2020, then tumbled by 32.43% to $50.0 million in 2021, then tumbled by 70.0% to $15.0 million in 2022, then soared by 333.33% to $65.0 million in 2023, then decreased by 7.69% to $60.0 million in 2024.
  • The last three reported values for Long-Term Debt Repayments were $60.0 million (Q4 2024), $40.0 million (Q3 2024), and $35.0 million (Q2 2024) per Business Quant data.